Dialysis News and Research

Latest Dialysis News and Research

UK House of Commons Health Committee publishes its long-awaited Report on obesity

Obesity has grown by almost 400% in the last 25 years such that three-quarters of the adult population are now overweight or obese (around 22% are now obese). England has witnessed the fastest growth in obesity in Europe and childhood obesity has tripled in twenty years.

27 May 2004

Minority women are disproportionately impacted by the autoimmune disease lupus

There is an urgent need for more education and research to address the fact that minority women are disproportionately impacted by the autoimmune disease lupus

14 May 2004

CMS announces 2005 Medicare Advantage payment rates

The Centers for Medicare & Medicaid Services today released the Medicare Advantage (formerly Medicare + Choice) payment rates for 2005.

11 May 2004

Cinacalcet drug more successful than a placebo in treating hyperparathyroidism

Research led by Saint Louis University physicians has shown that a new drug can help control one of the most common side effects of kidney disease.

29 Apr 2004

Two recent innovations look set to revolutionize biomedical treatment.

The first innovation is probably the world’s first multiple drug-eluting biodegradable stent for use in any part of the body where fluid flow, including blood, is disrupted.

19 Apr 2004

Transplants of older kidneys work as well as younger ones

According to the article, in the United States, the percentage of deceased kidney donors aged 55 and older has increased during the last decade. This is the result of both lower death rates (particularly from trauma) in people aged 18 to 35, and an increased acceptance of kidneys from older deceased donors.

12 Apr 2004

Cinacalet helps control overactive thyroids, a major complication of advanced kidney disease

A new drug can help control an overactive thyroid, a major complication of advanced kidney disease, by playing a trick on the gland, a new study finds. The drug, cinacalet, is much more effective at keeping the parathyroid gland working normally than a placebo, according to the study. It may be a good alternative to standard therapy, researchers said.

7 Apr 2004

New Zealand researcher awarded largest renal failure grant ever

With the incidence of kidney failure on the increase in this country, it is timely that the NZ Kidney Foundation has recently awarded a $76,000 grant to Professor Zoltan Endre to further research into renal failure. The grant is the largest single amount awarded by the NZ Kidney Foundation and has been largely funded from funds donated via an ongoing nationwide telephone appeal.

29 Mar 2004

Approval for FOSRENOL (lanthanum carbonate), which controls phosphate levels in renal dialysis patients

Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.

25 Mar 2004